AN OBSERVATIONAL STUDY OF HEPATITIS C INFECTION IN PREGNANT WOMEN BY USING SEROLOGICAL DIAGNOSTIC METHOD.

Main Article Content

Dr Kailash Jatav
Chesta Rani
Ravi Kumar

Keywords

Hepatitis C virus, Antenatal care, Enzyme linked immunosorbent assay, Pregnancy.

Abstract

Hepatitis C virus infection remains a significant public health problem worldwide. Over 71 million people’s deaths result from complications of untreated chronic HCV infection. A major barrier to HCV elimination still results from the fact that a substantial proportion of patients with chronic HCV infection are unaware of their infection, with large variations across different regions, countries and risk populations. Pregnant women constitute a vulnerable population due to the risk of vertical transmission. This study aims to determine the seroprevalence of HCV infection among pregnant women attending the Antenatal care in Index medical college, department of microbiology.


Objective: To Assess the demographic and risk factors associated with HCV positivity and highlight the importance of routine HCV screening in antenatal care. Seropositive cases with gestational diabetes and risk factors associated with acquisition of HCV infection & to estimate the HCV infection by detecting antibody and/ or antigen by ELISA/Rapid test.


Method: An observational study design was used. Pregnant women attending the ANC clinic during the study period were screened for HCV antibodies using Standard ELISA technique. Demographic and clinical data were collected using a structured questionnaire in our ANC department clinic of Index medical college & hospital Indore.


Result: Out of the 109 pregnant women attending ANC clinic in institute a total of 3 were found to be positive for anti-HCV antibody & confirm by ELISA test where 2.7% seropositive rate were found to be in this study.


Conclusion: In our study were concluded that insignificant seroprevalence of HCV in pregnant women those who attend the ANC department of index medical college. Early detection enables counseling and monitoring. Direct-acting antiviral (DAA) therapy can be planned postpartum. Infants born to HCV-positive mothers can be followed up for timely diagnosis.

Abstract 41 | Pdf Downloads 14

References

1. Hanafiah KM, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus Infection:new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333 1342. doi: 10.3748/wjg.v22.i34.7824
2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558-567. doi: 10.1016/S1473 3099(05)70216-4
3. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999;6(1):35-47. doi: 10.1046/j.1365 2893.1999.6120139.
4. Wasley A, Alter MJ. Epidemiology of hepatitis C:geographic differences and temporal trends. Semin Liver Dis. 2000;20(1):1-16. doi: 10.1055/s-2000-9506
5. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):41-46. doi: 10.7150/ ijms.3.41
6. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436-2441. doi: 10.3748/wjg.v13.i17.2436
7. Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol. 2003;36(1):47-45. doi: 10.1097/00004836-200301000 00015
8. Chattopadhyay S. Hepatitis C. A major health problem of India. Curr Sci. 2002;83:9. https://www. currentscience.ac.in/Volumes/83/09/1058.pdf
9. Roudot-Thoraval F. Epidemiology of hepatitis C virus infection. Clin Res Hepatol Gastroenterol. 2021;45(3):101596. doi: 10.1016/j.clinre.2020.101596
10. Hissar SS, Kumar M, Tyagi P, et al. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. J Gastroenterol Hepatol. 2009;24(4):581-587.
11. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999;6:35–47.
12. World Health Organization. Hepatitis C Virus. Available at http://www.who. int/vaccine_research/diseases/viral_cancers/en/index2.html. Retrieved on 3 November 2012.
13. Umar M, Bushra HT, Ahmed M, Khuram M, Usman S, Arif M, et al. Hepatitis C in Pakistan: A Review of Available Data. Hapat Mon. 2010;10(3):205-214.
14. Silverman NS, Jeukin BK, WOC, MeGilleu P, Knee G. Hepatitis C Virus in pregnancy: Seropervaleuce and risk factors for infection. Am Obstet Gynaecol. 1993;169(3):583-587. Yousfani S, Mumtaz F, Memon A, Memon MA, Sikandar R. Antenatal screening for Hepatitis B and C virus carrier state at a University Hospital. J Liaquat Uni Med Health Sci. 2006;5(1):24-27.
15. Delaunay CL, Cox J, Klein M, Lambert G, Grace D, Lachowsky NJ, et al. Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montréal: results from three cross-sectional studies (2005, 2009, 2018). Sex Transm Infect. 2005;97(4):290–6.
16. Garvey P, Grady B, Franzoni G, Bolger M, Crosby KI, Connell J, et al. Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera. Euro Surveill. 2014;22(30):30579.
17. Jindal N, Goyal LD, Singh C. Sociodemographic features associated with Hepatitis C Virus (HCV) in pregnant females: A tertiary care centre study from Malwa region of Punjab (North India). Journal of Family Medicine and Primary Care. 2021;10:2679.
18. Goyal LD, Kaur S, Jindal N, Kaur H. HCV and pregnancy: prevalence, risk factors, and pregnancy outcome in north Indian population: a case-control study. J Obstet Gynecol Ind. 2014;64:332-6.
19. Mehta KD, Antala S, Mistry M, Goswami Y. Seropositivity of hepatitis B, hepatitis C, syphilis, and HIV in antenatal women in India. J Infect Dev Ctries. 2013;7:832-7.
20. Yadav K, Verma P, Mishra PK, Yadav SK, Tripathi SK. seroprevalence of hepatitis B, Hepatitis C, Syphilis, Human Immunodeficiency Virus and Co-infections among Antenatal Women in a Tertiary care Hospital, Uttar Pradesh, India. J Pure Appl Microbiol. 2022;16:435-40.
21. Jahan G, Jahan N, Rungta S, Ahmad A. Seroprevalence and risk factors of hepatitis B and C infections among pregnant women. Int J Res Med Sci. 2020;8:1718-23
22. Malhotra P, Nanda S, Malhotra V, Chauhan M, Malhotra N, Chugh A, Chaturvedi A, Chandrika P, Singh I. Prevalence of HIV, Hepatitis B, Hepatitis C in Pregnancy at Tertiary Care Center of Northern India. Adv Res Gastroentero Hepatol. 2016;1(4):555568.
23. Parthiban R, Shanmugams, Velu V, Nandakumar S, Dhevahi E, Thangaraj K et al. Transmission of hepatitis C virus infection from asymptomatic mother to child in southern India. Int J Infect Dis. 2009;13:394-400.
24. Kumar A, Sharma KA, Gupta RK. Prevalence & risk factors for hepatitis C virus among pregnant women. Indian J Med Res. 2007;126:4211-5.
25. Jahan N, Chaudhary N, Nigar A, Ahmad S, Khatoon R, Kumar A. Prevalence of hepatitis C among pregnant females attending antenatal clinic at a tertiary care hospital in Lucknow, Uttar Pradesh, India. Int J Adv Med. 2020;7:314-8.
26. Pyadala N, Maity SN, Kothapalli JK, Goud A, Borugadda R, Mallepaddi PC, et al. Seroprevalence of HCV Infection among pregnant women in a rural teaching hospital, sangareddy. Int J Res Dev Pharm L Sci. 2006;5:2251-4.
27. Marwah S, Mohindra R, Sharma S, Mohan PV. Pattern of hepatitis B and C infection among gravid women and their newborns in a tertiary care infirmary in India. Int J Reprod Contracept Obstet Gynecol. 2020;5:354-60.
28. Pergam SA, Wang CC, Gardella CM, Sandison TG, Phipps WT, Hawes SE. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol. 2008;199:38.
29. Qamar TA, Naz U, Hira AK, Naz U, Jabbar S, Kazi S. Frequency of Gestational Diabetes in Pregnant Women with Hepatitis C in Civil Hospital Karachi. Pak J Med Sci. 2022;16:600-3.
30. Pinnetti C, Floridia M, Cingolani A, Visconti E, Cavaliere AF, Tamburrini E. Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART HIV Clinical Trials. 2009;10:403-12.

Most read articles by the same author(s)